BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/22/2021 12:14:42 PM | Browse: 290 | Download: 750
 |
Received |
|
2021-01-04 16:14 |
|
Peer-Review Started |
|
2021-01-04 16:16 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-01-23 12:41 |
|
Revised |
|
2021-02-05 19:09 |
|
Second Decision |
|
2021-03-25 12:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-03-26 04:14 |
|
Articles in Press |
|
2021-03-26 04:14 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-04-01 01:40 |
|
Publish the Manuscript Online |
|
2021-04-22 12:14 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Hung-Yuan Su and Yin-Chou Hsu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yin-Chou Hsu, MD, Staff Physician, Department of Emergency Medicine, E-DA Hospital, I-Shou University, No.1, Yida Road, Jiao-su Village, Yan-chao District , Kaohsiung 82445, Taiwan. yinchou0406@gmail.com |
| Key Words |
COVID-19; SARS-CoV-2; Cirrhosis; Acute liver injury; Prognosis; Therapy |
| Core Tip |
Several studies have addressed the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with cirrhosis. The presence and stage of cirrhosis is correlated with the development of severe coronavirus disease-2019 (COVID-19), COVID-19-related adverse outcomes, and mortality. It remains unclear whether SARS-CoV-2 infection is a trigger of acute decompensation or acute-on-chronic liver failure in cirrhotic patients based on the current evidence. There is still no clearly proven effective pharmacological treatment for cirrhotic patients with COVID-19. Clinicians should maintain standard cirrhosis care, defer unnecessary liver-specific procedures and have a low threshold for admission if cirrhotic patients are infected with SARS-CoV-2. |
| Publish Date |
2021-04-22 12:14 |
| Citation |
Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives. World J Clin Cases 2021; 9(13): 2951-2968 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i13/2951.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i13.2951 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
